Highest-materiality recent filing
Lease for 54,374 sq ft at 9955 Pacific Heights Blvd, San Diego; initial monthly base rent $315,369 ($5.80/sq ft) with 3% annual escalations.
Quantum-Si shareholders reelect all 10 directors, ratify auditor, approve say-on-pay
All 10 director nominees elected with >444M votes for each; highest for Jonathan Rothberg (454M for).
Quantum-Si Q1 net loss widens to $21.7M; Proteus sequencing milestones on track
Revenue of $258,000, gross margin 29%; net loss $21.7M vs $19.2M YoY.
Fourth quarter 2025 revenue was $451,000, gross margin 27%, and net loss $17.6 million.
Quantum-Si Incorporated posts updated corporate presentation on December 29, 2025
Company posted updated corporate presentation on its website on December 29, 2025.
Quantum-Si targets Proteus launch in Q4 2026 with 20-AA detection by 2027
Proteus product launch set for YE2026; first integrated system expected Q1 2026.
Revenue $552K; gross profit $194K, gross margin 35%.
Quantum-Si enters $100M at-the-market equity offering agreement with Leerink Partners
May offer and sell up to $100M of Class A common stock at its discretion through Leerink Partners as sales agent.
Quantum-Si pays $11M to settle lease litigation and terminate New Haven lease
Settles lawsuit with landlord Winchester Office LLC; terminates lease at 115 Munson St, New Haven effective Sept 23, 2025.
Quantum-Si furnishes updated corporate presentation; no material changes disclosed
Corporate presentation posted to investors section of company website on August 8, 2025.
Quantum-Si Q2 revenue $591K, net loss $28.8M; raises $50M cash runway
Q2 2025 revenue $591K; gross margin 59%; net loss $28.8M vs $23.1M prior year.
Quantum-Si prices $50M registered direct offering of stock and pre-funded warrants at $1.67
Gross proceeds ~$50M from sale of 29,940,119 shares (including pre-funded warrants) at $1.67 per share.
Quantum-Si shareholders reelect 10 directors, ratify PwC, approve say-on-pay
All 10 director nominees reelected; each received over 99% of votes cast excluding broker non-votes.
Quantum-Si Q1 revenue $842K (+84% YoY); launches Platinum Pro, cash runway to H2 2027
Revenue $842K (+84% YoY); gross profit $486K, gross margin 58%.
Quantum-Si posts updated corporate presentation on website, no new material details disclosed
Filed under Item 7.01 Regulation FD; presentation furnished as Exhibit 99.1.
Revenue $1.2M Q4 2024, $3.1M full year 2024 (+183% YoY). Gross margin 51% Q4, 52% FY.
Quantum-Si prices $50M registered direct offering of 15.6M shares at $3.20 each
Sold 15,625,000 shares at $3.20/share; gross proceeds ~$50M; closing expected Jan 6, 2025.
Quantum-Si enters $75M ATM equity facility with Canaccord; ends prior Evercore deal
Enters Equity Distribution Agreement with Canaccord Genuity for up to $75M of Class A common stock.
Quantum-Si regains Nasdaq minimum bid price compliance; delisting risk lifted for now
Received notice on Nov 4, 2024 that common stock bid price closed below $1.00 for 30 consecutive days; non-compliance with Nasdaq Listing Rule 5450(a)(1).
Quantum-Si to cut ~23% of workforce in restructuring; expects $2.6M in charges
Terminating approximately 23% of 187 employees; restructuring to streamline resources.
Quantum-Si holds Investor & Analyst Day; no specific new details in furnished presentation
Company presented at Investor & Analyst Day on November 20, 2024; slides furnished as Exhibit 99.1.
Quantum-Si corrects compliance date for Nasdaq bid price deficiency to May 5, 2025
Nasdaq notified Quantum-Si on Nov 4, 2024 that bid price below $1.00 for 30 consecutive days.
Quantum-Si Q3 revenue $787k; CEO warns full-year revenue guidance unlikely
Q3 2024 revenue $787k, gross margin 47%; net loss $25.3M vs $24.7M a year ago.
Quantum-Si receives Nasdaq bid price deficiency notice; must regain compliance by May 5, 2024
Closing bid price of Class A common stock (QSI) below $1.00 for 30 consecutive business days as of Nov 4, 2024.
Quantum-Si appoints Bennett as CCO, Vieceli as CPO, Thompson as CHRO; Johnston resigns
Todd Bennett appointed Chief Commercial Officer effective Sept 17, 2024; Grace Johnston resigns effective Sept 6.
Quantum-Si posts updated corporate presentation with no material new details
Company made updated corporate presentation available on its website on August 12, 2024.
Quantum-Si Q2 2024 revenue $622K, net loss narrows to $23.1M; launches v3 sequencing kit
Q2 revenue $622K, gross margin 57%; net loss $23.1M vs $25.6M YoY.
Quantum-Si posts updated corporate presentation to website
Updated presentation made available on ir.quantum-si.com on June 25, 2024.
Quantum-Si dismisses Deloitte, appoints PwC as auditor; discloses prior material weaknesses
Appointed PwC as independent auditor for FY2024, effective June 4, 2024, subject to client acceptance.
Quantum-Si appoints former Bio-Techne CEO Chuck Kummeth as independent Chairman
Kummeth, former Bio-Techne CEO for 11 years, elected independent Chairman effective May 27, 2024.
Quantum-Si discloses shareholder class action lawsuit over SPAC merger process
Lawsuit filed May 16, 2024 in Delaware Court of Chancery; plaintiff Farzad v. HighCape Capital, et al.
Charter amendment approved: removes director cap (460,048,611 for, 401,937 against) and adds automatic Class B conversion on June 10, 2028 (398,750,000 Class B votes for, 0 against).
Quantum-Si reports Q1 revenue $457K, net loss $19.5M; launches Platinum instrument
Revenue of $457,000; gross profit $269K at 59% margin.
Quantum-Si posts updated corporate presentation; no specific data extracted from exhibit
Corporate presentation posted to investors section of company website on April 9, 2024.
Quantum-Si appoints former Illumina executive Paula Dowdy to board
Paula Dowdy appointed to board effective March 21, 2024.
Quantum-Si amends CEO and CFO stock options with price-based vesting at $6-$12
CEO Jeffrey Hawkins: 1.5X Option (1.39M shares) and 3.5X Option (1.39M shares) amended with new performance vesting conditions.
Quantum-Si Q4 rev $400k, net loss $22M; full commercial launch expected by end Q1 2024
Revenue $400k in Q4 2023, $1.1M for FY2023; gross margin 45%.
Quantum-Si launches V2 Sequencing Kits with 3-fold cost reduction, new amino acid recognizer
V2 Sequencing Kit adds new amino acid recognizer, improved surface chemistry, reagents, and software.
Quantum-Si Q3 2023: $223k revenue, $24.7M net loss; controlled launch continues
Revenue of $223,000; gross profit $108,000 (48% margin); net loss $24.7M vs. $31.7M YoY.
Quantum-Si appoints biotech executive Amir Jafri to board of directors
Amir Jafri appointed to Board, effective September 22, 2023; Board size increased from 8 to 9.
Employment terminated August 31, 2023; separation pay of $356,250 lump sum.
Quantum-Si announces 16% workforce reduction; President/COO Schneider departs
Restructuring to cut ~16% of workforce; expects $2.5M cash severance charge and $0.3M non-cash stock option modification expense in H2 2023.
Quantum-Si Q2 revenue $205k, net loss $25.6M, cash runway into 2026
Revenue of $205,000 from Platinum instruments and consumables; gross margin 38.0%.
Quantum-Si EVP McKenna to separate effective July 31, 2023; receives $337,500 severance
Dr. Michael P. McKenna, EVP Product Development and Operations, leaves on July 31, 2023.
Quantum-Si appoints Johan Denecke as SVP of Operations; EVP Michael McKenna to depart July 31
Johan Denecke named SVP of Operations, effective June 20, 2023, responsible for scaling production and operational excellence.
Quantum-Si CFO Claudia Drayton to depart June 30; receives $300K severance, partially vested equity
Claudia Drayton stepped down as CFO on May 12, 2023; will serve as senior advisor until termination on June 30, 2023.
Quantum-Si appoints Jack Kenny to Board of Directors, effective May 19, 2023
Jack Kenny, CEO of Meridian Bioscience, appointed to Quantum-Si board effective May 19, 2023.
Charter Amendment limiting officer liability under Delaware law approved by shareholders (444.98M for, 6.55M against).
Quantum-Si Q1 revenue $254K, orders $449K; appoints Jeff Keyes CFO
Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8%.
Quantum-Si names Jeffry Keyes CFO; Claudia Drayton steps down effective May 15, 2023
Jeffry Keyes appointed CFO and Treasurer; start date on or before May 15, 2023.
On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.
The Company has appointed Todd Bennett as the Company’s new Chief Commercial Officer, effective as of September 17, 2024.
On May 27, 2024, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) elected Charles (“Chuck”) Kummeth to the Board and appointed him as Chairperson of the Board, each effective as of May 27, 2024
the Company’s current Chairperson of the Board, Jonathan M. Rothberg, Ph.D., continues to serve as a director of the Company but ceased serving as Chairperson of the Board.
the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Paula Dowdy to the Board, effective as of March 21, 2024.
On September 15, 2023, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Amir Jafri to the Board, effective as of September 22, 2023.
Pursuant to the Separation Agreement, Dr. Schneider’s employment with the Company terminated on August 31, 2023 (the “Separation Date”).
On August 28, 2023 (the “Effective Date”), the Company and Patrick Schneider, Ph.D. , the Company’s current President and Chief Operating Officer, mutually determined that Dr. Schneider w ill step down from such roles, effective as of the Effective Date.
the Company’s board of directors (the “Board”) appointed Jeffrey Hawkins, the Company’s current Chief Executive Officer and member of the Board, as President of the Company, effective as of the Effective Date.
As previously disclosed, Dr. McKenna will transition out of his role as of July 31, 2023.
mutually determined that Dr. McKenna will step down from such role, effective as of July 31, 2023.
Ms. Drayton stepped down as Chief Financial Officer and Treasurer of the Company on May 12, 2023
Max materiality 0.80 · Median 0.57 · Most common event other_material